Table 2 |
|||||||||
|
Mutations associated with RIF and INH resistance in the eight resistant isolates. |
|||||||||
|
RIF susceptibility pattern |
INH susceptibility pattern |
||||||||
|
KatG probes |
inhA probes |
||||||||
|
Study number |
Indirect Method |
rpoβ gene WT probes |
rpoβ gene Mutant probes |
Indirect Method |
WT |
Mutant |
WT1 |
WT2 |
Mutant |
|
|
|||||||||
|
08 |
R |
D516V, H526Y, H526D |
R |
WT |
wt |
WT |
C15T |
||
|
29 |
R |
D516V |
S |
WT |
WT |
WT |
|||
|
47 |
R |
D516V |
S |
WT |
WT |
WT |
|||
|
102 |
R |
R |
wt |
S315T1 |
WT |
WT |
|||
|
291 |
R |
Δ8 |
S531L |
R |
wt |
S315T1 |
WT |
WT |
|
|
246 |
S |
R |
wt |
S315T2 |
WT |
WT |
|||
|
248 |
R |
Δ1 |
S |
WT |
WT |
WT |
|||
|
437 |
R |
S531L |
S |
WT |
WT |
WT |
|||
|
|
|||||||||
|
INH = isoniazid; RIF = rifampicin; R = drug resistant isolate; S = drug susceptible isolate; Indirect method = proportion method on Lowenstein-Jensen media. |
|||||||||
|
Bazira et al. BMC Clinical Pathology 2010 10:5 doi:10.1186/1472-6890-10-5 |
|||||||||